Selective activation of group I metabotropic glutamate receptors (mGluRs) with (S)-3,5dihydroxyphenylglycine (DHPG) in guinea pig hippocampal slices converts 275-475 ms picrotoxin-induced interictal bursts into persistent seizure-length discharges typically over 1 sec in duration. Here we report that L-cysteine sulfinic acid (CSA), a sulfur-containing amino acid, prevented the induction of this persistent group I mGluR-mediated epileptiform burst prolongation. However, CSA had no effect on baseline interictal bursting activity and failed to suppress the expression of the group I mGluR-induced persistent prolonged bursts once they were fully induced. (2R,1'S,2'R,3'S)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine (PCCG-13), a selective antagonist at the phospholipase D (PLD)-coupled mGluR, had no effect of its own on DHPG-induced burst prolongation; however, CSA applied in the presence of PCCG-13 could no longer fully block the burst prolongation induced by DHPG, suggesting that CSA's antiepileptogenic effect is mediated by agonist action at this PLD-coupled receptor. These data parallel our previous data revealing that protein synthesis inhibitors prevent induction but not expression of group I mGluR-mediated persistent seizure-length discharges. Hence, PLD activation with CSA may prevent the synthesis of a protein critical for the induction of group I mGluR-mediated epileptogenesis.
INTRODUCTION
Epileptogenesis is the process in which normal cerebral cortex undergoes a long-lasting change which results in the persistent propensity for the production of seizure discharges. We have previously reported that transient exposure of hippocampal slices to (S)-3,5-dihydroxyphenylglycine (DHPG), a selective group I metabotropic glutamate receptor (mGluR) agonist, will elicit one form of epileptogenesis in vitro, converting reversible interictal bursts into persistent seizure-length synchronized discharges (Merlin and Wong 1997) . The persistent expression of the prolonged epileptiform discharges is sustained by the continued activation of group I mGluRs by endogenous glutamate (Merlin and Wong 1997; Merlin 1999) . Although both members of the group I mGluR family participate in both the induction and maintenance of these seizure discharges, mGluR1 selective antagonist is more effective at suppressing the expression of the prolonged bursts during the maintenance phase, while mGluR5 antagonist is better at preventing the induction process (Merlin 2002) . Experiments analogous to some long-term potentiation (LTP) studies revealed that the induction but not the maintenance of this mGluRmediated epileptogenesis is protein synthesis dependent (Merlin et al. 1998 ). However, unlike LTP, neither the induction nor the maintenance requires NMDA receptor activation (Galoyan and Merlin 2000) or active synchronized bursting activity (Merlin 1999) . DHPG has actions at phospholipase D (PLD)coupled mGluRs, which represent one type of a number of non-classical mGluRs described in brain (Schoepp et al. 1999 ). Here we demonstrate that L-cysteine sulfinic acid (CSA), an agonist at an as yet unnamed PLD-coupled mGluR (Boss et al. 1994) , can provide protection from group I mGluR-induced epileptogenesis. Portions of this work have appeared in abstract form (Rico and Merlin 2002a, b) .
METHODS

2-4
week old guinea pigs were anesthetized and decapitated in conformance with the Guide for the Humane Care and Use of Animals, and the brains were promptly removed and placed in ice-cold artificial CSF. The hippocampus was dissected free and 400 µm transverse slices were prepared using a Vibratome (Technical Products International), then transferred to nylon mesh in an interface recording 3 chamber (Fine Science Tools) maintained at 34.5-35.5°C and bubbled with 95% O 2 /5% CO 2 at pH 7.4.
Slices were perfused at a rate of 2-2.5 ml/min with artificial CSF containing (in mM) 124 NaCl, 26 NaHCO 3 , 5 KCl, 1.6 MgCl 2 , 2 CaCl 2 , and 10 D-glucose. Slices were allowed to rest for one hour, then continuous intracellular recordings were obtained from the CA3 stratum pyramidale using 25-90 MΩ glass microelectrodes filled with 2M potassium acetate. Data were amplified, digitized, and later analyzed using Axon Instruments equipment and software. 
RESULTS
CSA blocks DHPG-mediated induction of prolonged epileptiform bursts
Bath application of picrotoxin (PTX) typically elicited spontaneous interictal-length (i.e. <500 ms) epileptiform bursts in CA3 pyramidal cells in guinea pig hippocampal slices. Exposure to 50 µM DHPG, a selective group I mGluR agonist, promptly elicited a transient increase in burst frequency (peaking at 0.44 ± 0.04 Hz, n = 9) accompanied by a gradual conversion of the brief interictal bursts into prolonged seizure-length discharges that persisted upon agonist removal (see Merlin et al. 1998 ). In nine slices tested, the initial burst duration (BD interictal ) of 342 ± 8 ms was increased an average of 267 ± 49 % by 40 min of DHPG perfusion (BD DHPG 1235 ± 147 ms); this potentiation was significantly sustained one hour following DHPG washout (BD wash 1194 ± 111 ms; a 252 ± 34 % increase; Fig. 1A ). However, in nine experiments performed in the presence of 100 µM L-cysteine sulfinic acid (CSA), DHPG exposure for 40 min had no significant effect on the length of picrotoxin-induced interictal bursts (BD interictal 352 ± 5 ms; BD DHPG 402 ± 35 ms, an increase of 14 ± 9 %; P > 0.05; Fig. 1B ), although the DHPG-induced increase in burst frequency was not significantly impeded by CSA (interictal burst frequency of 0.11 Hz rapidly accelerated to 0.35 Hz during DHPG application in the presence of CSA; n = 9). CSA had no significant effect on baseline picrotoxin-induced interictal bursts (BD interictal 343 ± 11 ms at 0.09 ± 0.02 Hz; after 25 min CSA 338 ± 15 ms at 0.09 ± 0.02 Hz; n = 7).
*** INSERT FIGURE 1 HERE ***
PCCG-13 prevents CSA-mediated block of DHPG-induced burst prolongation
DHPG may activate PLD-coupled mGluRs (Klein et al. 1997; Albani-Torregrossa et al. 1999; Schoepp et al. 1999; see Discussion) . However, DHPG application in the presence of 1 µM PCCG-13, a selective antagonist at PLD-coupled mGluRs (Pellicciari et al. 1999) , elicited a DHPG response similar to that seen in controls (BD interictal 334 ± 15 ms; BD DHPG 1696 ± 482 ms, n = 6). Nevertheless, PCCG-13 did block the effect of CSA on the DHPG-induced burst prolongation; CSA (100 µM) could not prevent the DHPG-mediated induction of persistent prolonged bursts when applied in the presence of 1 µM PCCG-13. Interictal bursts of 366 ± 34 ms duration increased by 187 ± 61 % to 1023 ± 177 ms after 40 min exposure to DHPG in the presence of PCCG-13 and CSA (n = 4; P < 0.05; Fig. 2 ). PCCG-13 had no effect of its own on interictal burst duration (BD interictal 325 ± 9 ms; BD PCCG13 325 ± 11 ms, n = 6). The burst prolongation induced by DHPG application in the presence of CSA and PCCG-13 was not significantly different from that induced in the control condition by DHPG alone, but was indeed significantly different from DHPG application in the presence of CSA alone (P < 0.01; Fig. 2B ). ). Nevertheless, we report herein that exogenously-applied CSA at 100 µM did not significantly affect the frequency or duration of interictal bursts in the in vitro hippocampus, suggesting that at this concentration these excitatory effects are not powerful enough to enhance the network activities. Alternatively, CSA reuptake or degradation mechanisms, which are likely to be increased during epileptiform bursting (Do and Tappaz 1996; Grieve et al. 1991; Wu et al. 1998) , may be suppressing the predicted excitatory effects. Additional action of CSA at group II mGluRs (Maione et al. 1998 ) may compensate even further, reducing the net excitatory effect by enhancing long-term depression (Otani et al. 2002) . CSA is also reported to suppress GABA A receptor-mediated inhibition (Morishita and 6 Alger 1999); this excitatory effect, however, does not come into play here because we used a GABA A antagonist to elicit the baseline interictal activity in our experiments.
CSA-mediated activation of the PLD-coupled mGluR prevents group I mGluR-induced epileptogenesis
Another reported effect of CSA is activation of a phospholipase D-coupled metabotropic receptor (Boss et al. 1994) , an action which can be competitively antagonized by PCCG-13 (Pellicciari et al. 1999 ). It should be noted that DHPG itself can non-competitively antagonize the PLD-coupled metabotropic receptor in adult rat hippocampal slices with an IC 50 of 70 µM (Albani-Torregrossa et al. 1999 ), while inducing full agonist PLD responses in 8-day-old rats (Klein et al. 1997) . In our experiments, PCCG-13 successfully suppressed the CSA effect (see Fig. 2 ), suggesting that the site of CSA action is the PLD-coupled receptor. Yet if CSA is activating this receptor, it implies that DHPG is not effectively blocking this receptor in our system. Furthermore, given that PCCG-13 had no effect on DHPG-induced epileptiform activities, DHPG does not appear to be acting as an agonist at this receptor. This lack of agonist or antagonist effect of DHPG may be due to the intermediate age of the animals (2-4 weeks, which is supposed to be neurologically mature in guinea pigs) or interspecies variability.
Hence it is the action of CSA at the PLD-coupled metabotropic receptor that enables it to be effective against the induction of epileptogenesis, while it has no impact on either interictal (Fig 1) or fully-developed ictaform bursts (Fig 3) . These findings are directly parallel to experiments with protein synthesis inhibitors, which also reveal an ability for these agents to prevent the induction of long-lasting ictaform bursts without affecting interictal bursts or fully-developed ictaform bursts and without blocking the DHPG-induced increase in burst frequency (see Merlin et al. 1998) . It is possible that phospholipase D activation prevents the synthesis of a protein that is critical to the induction of persistent ictaform events. The identity of this critical protein remains to be determined. Nevertheless, the absence of effect of CSA on interictal or ictal bursting activities suggests that there may be a clinically useful concentration of CSA that will allow for normal neuronal network functioning while preventing pathological mGluRinduced long-term modifications such as epileptogenesis. Fig. 3 . CSA has no effect on the sustained expression of DHPG-induced persistent prolonged bursts. A.
Representative example of effect of CSA (100 µM, introduced at 1 hr of DHPG washout) on DHPGinduced fully developed prolonged discharges. Representative traces from experiment in A are shown to right at times indicated. As CSA was introduced at 60 min DHPG washout, "30 min CSA" corresponds to 90 min washout of DHPG. B. Summary data, n = 4 for Control, n = 6 for CSA. For the CSA group (gray bars), "90 min wash" corresponds to 30 min CSA application (as shown in A). Residual potentiation for each slice during washout normalized against its own peak BD increase at the end of 40 min DHPG application (BD peak -BD ptx ), and was calculated as (BD x min wash -BD ptx ) x 100 / (BD peak -BD ptx ). 
